NEW YORK (GenomeWeb) – The Translational Genomics Research Institute and George Mason University today said that they will integrate genomics, proteomics, and molecular profiling in an alliance aimed at finding personalized treatments for patients.

The TGen-George Mason Molecular Medicine Alliance will pair TGen's genomics capabilities with research carried out at George Mason's Center for Applied Proteomics and Molecular Medicine. Their goal is to apply and study personalized methods for treating patients with cancer and other life-threatening conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.